52nd Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
May 6 - 10, 2011
McCormick Place - Chicago, Illinois
during Digestive Disease Week®
Program and Abstracts | Posters
![]() |
The Plenary presentations, Presidential Address, and Doris and John L. Cameron Guest Oration from the Monday morning scientific sessions are all available online. Watch the synchronized PowerPoint and audio of each speaker by clicking on the "![]() |
![]() |
indicates a ticketed session requiring a separate registration and fee. |
![]() |
indicates the papers also being presented at the Residents & Fellows Research Conference. Participation in and attendance at this conference is by invitation only. |
Welcome and introduction of new members, announcements of SSAT scholarship awards, reports from the SSAT Foundation, recognition of the Foundation donors, and conferment of the Founders Medal.
Happy Mother's Day
David W. Rattner, Boston, MA
View Presentation
Bioengineering and Clinical Applications of Circulating Tumor Cell Microchip
Mehmet Toner, Charlestown, MA
View Presentation
DEBATE 1: NISSEN FUNDOPLICATION IS UNDERUTILIZED IN THE TREATMENT OF GERD
Moderator: Craig P. Fischer, Houston, TX
Frame the Issue
Craig P. Fischer, Houston, TX
Surgical Fundoplication Saves Money, Prevents Cancer, and Is Underutilized
Mehran Anvari, Hamitlon, ON
We Have It Just Right. A Small Minority of Patients Will Benefit from Surgical Approaches to GERD; Medication and Close Observation is Appropriate for the Vast Majority
Chin Hur, Boston, MA
Panel and Audience Discussion
DEBATE 2: ROBOTICS APPLICATIONS IN GASTROINTESTINAL SURGERY: INDUSTRY SPONSORED HEALTH CARE INFLATION OR REAL ADVANCE THAT WILL BENEFIT PATIENTS?
Moderator: Brian Dunkin, Houston, TX
Frame the Issue
Brian Dunkin, Houston, TX
The Robot Is Not a Glorified Sewing Machine; It's a Real Advance for Patients and Surgeons
Sayeed Ikramuddin, Minneapolis, MN
What You Can Do with Your Robot, I Can Do with My Laparoscope Faster and Cheaper
Lee Swanstrom, Portland, OR
Panel and Audience Discussion
Moderators: | Jeffrey H. Peters, Rochester, NY Peter J. Kahrilas, Chicago, IL |
What Is PPI Failure from a Surgical Perspective and What Subsets of Patients Are More Likely to Respond to Surgical Management?
John G. Hunter, Portland, OR
The Role of Symptom Profiling and Physiological Testing in Subtyping Refractory Patients
Michael Vaezi, Nashville, TN
PPIs in Relation to Barrett's: Preventative? Post-Ablation? Reduced Cancer Risk?
Prateek Sharma, Kansas City, MO
Panel Discussion
Moderators: | Michael Rosen, Cleveland, OH C. Daniel Smith, Jacksonville, FL |
Introduction
Taylor S. Riall, Galveston, TX
Overview of Personalized Medicine in GI Cancers: Different Things to Different People
Celia Chao, Galveston, TX
Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colon Cancer
John M. Carethers, Ann Arbor, MI
Personalized Medicine in Pancreatic Cancer: Potential Implications for Therapy
Christine A. Iacobuzio-Donahue, Baltimore, MD
Personalized Therapy: Prognostic Factors for GIST
Ronald P. DeMatteo, New York, NY
Panel and Audience Discussion
Moderators: | Elijah Dixon, Calgary, AB Jean Nicolas Vauthey, Houston, TX |